View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
TREAS/IRS RIN: 1545-BJ39 Publication ID: Fall 2014 
Title: Branded Prescription Drug Fee 
Abstract:

Implementation of section 9008 applies to imposition of annual fee on branded prescription pharmaceutical manufacturers and importers, of the Patient Protection and Affordable Care Act of 2010, Public Law 111-148.

 
Agency: Department of the Treasury(TREAS)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Completed Actions 
Major: No  Unfunded Mandates: No 
CFR Citation: 26 CFR 51   
Legal Authority: 26 USC 7805    PL 111-148, sec 9008    26 USC 6302   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  08/18/2011  76 FR 51310   
NPRM Comment Period End  11/16/2011 
Completed by TD 9684  07/28/2014  79 FR 43631   
Additional Information: REG-112805-10 Drafting attorney: Celia Gabrysh (202) 317-6855 Reviewing attorney: Charles Langley (202) 317-6855 CC:PSI
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Related RINs: Related to 1545-BK34 
Agency Contact:
Celia Gabrysh
Attorney-Advisor (Tax)
Department of the Treasury
Internal Revenue Service
1111 Constitution Avenue NW., Room 5309,
Washington, DC 20224
Phone:202 317-6855
Fax:202 317-6733
Email: celia.gabrysh@irscounsel.treas.gov